RxDoctor Payments Data

Alejandro Polania

Physician Assistant · Albuquerque, NMNPI 1750871299

Payments from drug & device makers

$893in general payments, 2019–2025

Across 47 payments — averaging $19.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$196
  • AstraZeneca$167
  • Amgen$93
  • E.r. Squibb & Sons, L.L.C.$86
  • Abiomed$69
  • Johnson & Johnson$47
  • plus $235 from 8 others

What the payments were for

  • Food & beverage$893100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$893 in reported general payments places this provider in the 75th percentile of 635 physician assistant providers in New Mexico.

See all physician assistant providers in New Mexico

Medicare billing

Part B allowed, 2024
$12,802
Medicare patients
149
Services billed
165

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XareltoRivaroxaban95$124,453
EliquisApixaban67$77,211
EntrestoSacubitril/Valsartan21$38,279
Repatha SureclickEvolocumab36$25,078
BrilintaTicagrelor16$7,120
Atorvastatin Calcium312$4,823
Metoprolol Succinate206$3,828
ClopidogrelClopidogrel Bisulfate156$2,405
Rosuvastatin Calcium105$1,912
Losartan Potassium108$1,833
Lisinopril160$1,533
Ezetimibe50$1,302
Isosorbide Mononitrate ErIsosorbide Mononitrate68$1,302
Metoprolol Tartrate85$1,063
Flecainide Acetate32$1,004

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$47$124,45395 claims
PfizerEliquis$22$77,21167 claims
NovartisEntresto$196$38,27921 claims
AstraZenecaBrilinta$167$7,12016 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 635 physician assistant providers in New Mexico.

Other physician assistant in Albuquerque

See the full list for New Mexico

Where these figures come from

Is this you, or does something look wrong? →